OPA1 and metabolic dysfunction-associated steatohepatitis: Those studies indicated that OPA1 depletion blocks mitochondrial fusion and thus prevents the formation of mega-mitochondria in NASH, which in turn increases mitophagy to mitigate the liver pathology.